Greater focus on OTC derivatives op risk required in Asia – Celent

clearing and settlement

Operational risk in the over-the-counter derivatives market has come into sharper focus during the past four to five years, particularly in the wake of the global financial crisis. But more attention is needed, especially given the advent of trade repositories and central counterparty (CCP) clearing in the region, which could pose substantial challenges for smaller dealers, according to a new report, Operational Risk Management in OTC Derivatives in Asia, published by Celent.

Although

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

If you already have an account, please sign in here.

Register

Want to know what’s included in our free membership? Click here

This address will be used to create your account

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: